2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Molecular and biochemical basis <strong>of</strong> disease<br />
Polymorphisms C677T and A1298C in MTHFR gene have been associated<br />
with a varying risk <strong>of</strong> cervical dysplasia . We evaluated the<br />
association <strong>of</strong> C677T and A1298C polymorphisms at the MTHFR<br />
locus with cervical intraepithelial neoplasia (CIN) or cervical cancer<br />
(CC) in Yucatan, Mexico, where CC is the first most common cancer.<br />
A case-control study was performed . Cases were 84 DNA samples <strong>of</strong><br />
women with CIN or CC (47 CIN I, 14 CIN II, 7 CIN III, 9 invasive cervix<br />
cancer and 7 cervical cancer) and controls were 127 DNA samples <strong>of</strong><br />
women who were negative to PAP . Polymorphisms were determined<br />
by PCR-RFLPs . Allele and genotype frequencies were compared between<br />
cases and controls in EpiInfo s<strong>of</strong>tware (OR, IC 95%) . Genotype<br />
frequencies in cases and controls were according to Hardy-Weinberg<br />
expectations (p>0 .33) for both polymorphisms . For C677T-MTHFR<br />
polymorphism, allele and genotype frequencies were not significantly<br />
different between cases and controls (p>0 .05), whereas for A1298C<br />
polymorphism, frequency <strong>of</strong> allele C was significantly different between<br />
cases and controls (P=0 .0325), suggesting an association <strong>of</strong><br />
1298C allele with a reduced risk to CIN or CC (OR 0 .51, IC 0 .25-0 .98) .<br />
Stratification according to phenotype showed that heterozygous genotype<br />
AC and allele C were associated only with CIN I, p= 0 .023 and p=<br />
0 .0180, respectively . Our results suggest that polymorphism A1298C<br />
in MTHFR gene is associated to CIN I as a protective factor to develop<br />
more severe dysplasias in Yucatan population .<br />
P06.187<br />
mtHFR gene polymorphisms and neural tube defects - the<br />
incidence in slovak population.<br />
J. Behunova 1 , L. Klimcakova 2 , D. Potocekova 3 , L. Podracka 1 ;<br />
1 I. Department <strong>of</strong> Pediatrics, Safarik University Children Hospital, Kosice, Slovakia,<br />
2 Department <strong>of</strong> Medical Biology, Safarik University School <strong>of</strong> Medicine,<br />
Kosice, Slovakia, 3 Department <strong>of</strong> Informatics, Safarik University School <strong>of</strong><br />
Medicine, Kosice, Slovakia.<br />
Neural tube defects (NTD) belong to the most debilitating birth anomalies<br />
. The geographical & historical differences in NTD incidence vary<br />
tremendously - from 8/1000 till 0,21/1000 . Discovery <strong>of</strong> folic acid´s preventive<br />
effect influenced the research <strong>of</strong> NTD genetic background focusing<br />
to the genes whose products take part in the folate metabolism .<br />
One <strong>of</strong> the most important enzymes involved is MTHFR - methylenetetrahydr<strong>of</strong>olate<br />
reductase whose common termolabile variant C677T<br />
in homozygote state reduces MTHFR activity to 30-40% <strong>of</strong> norm . Lowered<br />
activity might play a crucial role in early embryonic development .<br />
That is why this polymorphism has been investigated in various NTD<br />
populations and in some <strong>of</strong> them the mutant variant has been proven<br />
to be a risk factor for failure <strong>of</strong> neural tube closure .<br />
In Slovakia with average natality about 50 000 liveborn per year, there<br />
are anually 10-20 children born with NTD (0,28/1000) - mostly with<br />
meningomyelocele . When including stillborn and selective abortions,<br />
the number <strong>of</strong> NTD pregnancies is even higher (0,35-0,52/1000) . To<br />
evaluate genetic risk <strong>of</strong> folate metabolism variations in our population,<br />
we investigated MTHFR gene polymorphisms C677T and A1298C in<br />
91 Slovak children with NTD . The obtained results <strong>of</strong> genetic analyses<br />
are being compared with those from 300 newborns from Slovak population<br />
. Currently we got the results <strong>of</strong> C677T polymorphism analysis,<br />
which, however, did not show any significant difference in the prevalence<br />
<strong>of</strong> TT genotype or T allele between the patients and controls (OR<br />
= 1,22 [95% CI 0,5-2,9]; OR = 1,16 [CI 0,8-1,7] respectively) .<br />
P06.188<br />
Use <strong>of</strong> a Genetic isolate to identify Rare ms Variants<br />
S. P. Kallio 1 , E. Jakkula 1,2 , S. Purcell 2,3 , M. Suvela 1 , K. Koivisto 4 , P. J. Tienari 5 ,<br />
M. L. Sumelahti 6 , I. Elovaara 7 , T. Pirttilä 8 , M. Reunanen 9 , D. Bronnikov 1 , M.<br />
Viander 10 , J. Hillert 11 , F. Lundmark 11 , H. F. Harbo 12 , Å. R. Lorentzen 13,14 , P. L. De<br />
Jager 2,15 , M. J. Daly 2,3 , D. A. Hafler 2,15 , A. Palotie 1,2 , L. Peltonen 1,16 , J. Saarela 1 ;<br />
1 National Public Health Institution, University <strong>of</strong> Helsinki and FIMM, Helsinki,<br />
Finland, 2 The Broad Institute <strong>of</strong> Harvard and MIT, Cambridge, MA, United<br />
States, 3 Center for <strong>Human</strong> Genetic Research, Massachusetts General Hospital<br />
and Harvard Medical School, Boston, MA, United States, 4 Central Hospital <strong>of</strong><br />
Seinäjoki, Seinäjoki, Finland, 5 Department <strong>of</strong> Neurology, University <strong>of</strong> Helsinki,<br />
Helsinki, Finland, 6 School <strong>of</strong> Public Health, University <strong>of</strong> Tampere, Tampere,<br />
Finland, 7 Department <strong>of</strong> Neurology, Tampere University Hospital, Tampere,<br />
Finland, 8 Department <strong>of</strong> Neurology and Neuroscience, Kuopio University Hospital,<br />
Kuopio, Finland, 9 Department <strong>of</strong> Neurology, Oulu University Hospital, Oulu,<br />
Finland, 10 Department <strong>of</strong> Medical Microbiology and Immunology, University <strong>of</strong><br />
Turku, Turku, Finland, 11 Department <strong>of</strong> Clinical Neuroscience, Karolinska Institutet<br />
at Karolinska University Hospital-Huddinge, Stockholm, Sweden, 12 Department<br />
<strong>of</strong> Neurology, Ullevål University Hospital, Oslo, Norway, 13 Institute <strong>of</strong><br />
Immunology, Rikshospitalet University Hospital, Oslo, Norway, 14 Department <strong>of</strong><br />
Neurology, Faculty Division Ullevål University Hospital, University <strong>of</strong> Oslo, Oslo,<br />
Norway, 15 Department <strong>of</strong> Neurology, Center for Neurologic Diseases, Brigham<br />
and Women’s Hospital and Harvard Medical School, Boston, MA, United<br />
States, 16 Wellcome Trust Sanger Institute, Cambridge, United Kingdom.<br />
MS is a chronic inflammatory disease <strong>of</strong> the CNS with complex inheritance<br />
. The etiology <strong>of</strong> MS is poorly understood . Large case-control association<br />
studies primarily aim to identify common variants contributing<br />
to pathogenesis <strong>of</strong> common traits . To tackle rare alleles contributing to<br />
the molecular background <strong>of</strong> MS, alternative strategies are needed .<br />
One approach is to use special populations with a founder effect and<br />
isolation, where one could hypothesize allelic enrichment . Such a<br />
unique high-risk region for MS is the Southern Ostrobothnia in Finland,<br />
where both the prevalence and familial occurrence are exceptionally<br />
high . We have performed a high-resolution genome-wide SNP study<br />
using the Illumina <strong>Human</strong>Hap300 panel to monitor, which alleles are<br />
shared by 72 familial MS cases from this high-risk isolate . Genealogical<br />
studies showed that majority <strong>of</strong> these patients are distantly related .<br />
Genotype data <strong>of</strong> 68 IBS-matched Finns was used as controls . We<br />
first focused on the 45Mb region on 5p, for which we have shown linkage<br />
in Finnish MS-families . The haplotype analysis over this region<br />
revealed association with one haplotype, and the finding was validated<br />
in a larger study set from the high-risk region (OR 2 .73, p=3 .2x10 -6 ) .<br />
The identified risk-haplotype flanks two genes, C7 (complement component)<br />
and FLJ40243 (predicted protein) . Suggestive association<br />
with C7-FLJ40243 alleles and MS was also seen in more heterogeneous<br />
populations . Interestingly, plasma C7 protein levels and total<br />
complement activity were observed to correlate with the risk-haplotype<br />
identified. Sequencing <strong>of</strong> the 31kb C7 region did not reveal an obvious<br />
causative variant . Sequencing <strong>of</strong> FLJ40243 is in progress .<br />
P06.189<br />
Genetic polymorphysms <strong>of</strong> iL12B and VDR in association with<br />
multiple sclerosis in russians<br />
S. Babenko1 , J. Orlova2 , V. Alifirova2 , V. Pusyrev1,2 ;<br />
1 2 Institute <strong>of</strong> Medical <strong>Genetics</strong>, Tomsk, Russian Federation, Siberian State<br />
Medical University, Tomsk, Russian Federation.<br />
We investigated genotypes and haplotypes frequencies for VDR and<br />
IL12B polymorphisms in case-control studies <strong>of</strong> MS in 92 Russian<br />
inhabitants <strong>of</strong> Tomsk region. Our results show significant differences<br />
<strong>of</strong> alleles and genotypes frequencies in the distribution <strong>of</strong> the polymorphism<br />
1188A>C IL12B between MS patients and controls (p